chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19-2, FLU3
Symptoms: Arthralgia, Imaging procedure, Inflammation, Joint adhesion
Clinical narrative: Patient received Prevnar 20 vaccine on 12/2/2022 in left arm. She returned to pharmacy on 12/7/2022 and received Moderna Bivalent in right arm and Fluzone HD in left arm. Patient stated after receiving the 2nd shot (Fluzone HD) in her left arm that she has been having pain in her shoulder area. She followed up with her PCP, and was eventually referred to another doctor where she has undergone imaging and physical therapy as well as receive medications for pain/inflammation for shoulder adhesions.
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Burning sensation, Chills, Headache, Injection site pain
Clinical narrative: Normal side effects after shot: headache, nausea,  muscle aches, chill, sore injection site, itching;  8/10 broke out in rash, both arms & trunk front & back.  Progressed to vesicles.  Looks like chicken pox : itching, burning, tender; Had e visit & MD confirmed (I had shingles in Jan 2017
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Nausea, Pruritus, Rash, Rash vesicular
Clinical narrative: Normal side effects after shot: headache, nausea,  muscle aches, chill, sore injection site, itching;  8/10 broke out in rash, both arms & trunk front & back.  Progressed to vesicles.  Looks like chicken pox : itching, burning, tender; Had e visit & MD confirmed (I had shingles in Jan 2017
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Tenderness
Clinical narrative: Normal side effects after shot: headache, nausea,  muscle aches, chill, sore injection site, itching;  8/10 broke out in rash, both arms & trunk front & back.  Progressed to vesicles.  Looks like chicken pox : itching, burning, tender; Had e visit & MD confirmed (I had shingles in Jan 2017
Age: 4.0
Sex: F
Vaccine: DTAPHEPBIP, IPV, MMRV
Symptoms: Extra dose administered
Clinical narrative: At event, provided vaccines for children. Client inadvertently given 2 doses IVP, I called pt / client's mother on 8/7/23 and report the incident. She stated patient is "fine", with no adverse effects from any of her shots.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Rash
Clinical narrative: Rash all over body.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional AE/PQC.; Caller reported AE on behalf of a patient who was administered an expired dose of MMR-II (no prior TEs). Caller confirmed that STERILE DILUENT was not expired. No symptoms reported.  Obtained consent to contact HCP. No additional AE/PQC.; This spontaneous report was received from a medical assistant regarding 1-year-old patient of unspecified gender. Information regarding medical history, concurrent conditions and concomitant medications was not reported.   On 15-AUG-2023, the patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) 0.5ml/dose (lot number U024229 and expiration date 04-AUG-2023 have been confirmed as valid) (no more vaccination details were reported). The reporter confirmed that the STERILE DILUENT was not expired. No symptoms reported. No additional adverse event (AE)/product quality complaint (PQC).
Sex: U
Vaccine: HIBV
Symptoms: Expired product administered
Clinical narrative: Confirmed no symptomatic adverse events were reported; Inbound call from medical assistant calling to report administration of expired PEDVAXHIB.; This spontaneous report has been received from a medical assistant, regarding a patient of unknown age and gender. The patient's pertinent medical history, past drug reactions or allergies, concurrent conditions and concomitant therapies were not provided.  On 18-AUG-2023, the patient was vaccinated with an expired dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (LIQUID PEDVAXHIB) intramuscular injection, at a dose of 0.5 milliliters once as prophylaxis (lot number: T037651, which was determined to be valid, with an expiration date on 20-JUL-2023) (strength, route and anatomical location of administration were not reported) (Expired product administered).  The reporter confirmed there were no symptomatic adverse events, and confirmed that product did not have any temperature excursions in the past.
Sex: U
Vaccine: HEPA
Symptoms: Product storage error
Clinical narrative: Nurse reported VAQTA was administered after improper storage.; This spontaneous report was received from a nurse, concerning to a unspecified age and gender patient. No information regarding the patient's medical history, previous drug reactions or allergies and concomitant medications was provided  On an unknown date, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 dose, vial, lot #X003791, expiration date: 01-JUN-2024 (who had been verified to be a valid number) administered for prophylaxis (strength, and route of administration were not provided).  On 21-JUL-2023, the vaccine was improper storage at temperature 51 degree Fahrenheit, with a time frame of 1 hour 0 minutes and 0 seconds. There was no information about previous temperature excursion (product storage error).
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: Medical Tech calls to report vaccine given during an excursion.  No PQC. No further AE; No further AE; This spontaneous report was received from a consumer and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (recombinant Human albumin (rHA), subcutaneous injection, one time, lot number w038815 that had been verified to be valid with expiration date: 04-JUN-2024, administered for prophylaxis (strength, and route of administration were not provided).  On 17-AUG-2023, the vaccine was given during an excursion (Product storage error). No PQC. No further AE.
Age: 0.67
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; Patient 6 months-5 years of age received a Moderna Covid19 vaccine from the pink cap vial (10 mcg) instead of blue cap vial (25 mcg; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient 6 months-5 years of age received a Moderna Covid19 vaccine from the pink cap vial (10 mcg) instead of blue cap vial (25 mcg) and NO ADVERSE EVENT (No adverse event) in an infant female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 216K22A and 214K22A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 26-Apr-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 10 microgram. On 27-May-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 10 microgram. In 2023, the patient experienced WRONG PRODUCT ADMINISTERED (Patient 6 months-5 years of age received a Moderna Covid19 vaccine from the pink cap vial (10 mcg) instead of blue cap vial (25 mcg). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient 6 months-5 years of age received a Moderna Covid19 vaccine from the pink cap vial (10 mcg) instead of blue cap vial (25 mcg) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient 6 months-5 years of age received a Moderna Covid19 vaccine from the pink cap vial (10 mcg) instead of blue cap vial (25 mcg).    The route of administration of suspect Moderna bivalent dose 1 and 2 was reported as BI. Concomitant medication was not reported. Treatment medication was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-730780 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-730780:Master case
Age: 24.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL); This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)) and NO ADVERSE EVENT (No adverse event) in a 24-month-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     The relevant medical history/conditions, allergy, concomitant diseases and risk factor was unknown.    On 29-Jun-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 27-Jul-2023, received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 27-Jul-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (HCP stated they had 12 patients from 6 months to 5 years not previously vaccinated, and accidentally they administered 2 doses 1 month apart (0.25 mL)).    Patient did not receive other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter. This case contains information for patient 12 out of 12.   This case was linked to US-MODERNATX, INC.-MOD-2023-737355 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-737355:Master case
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: Developed blood clots in left calf; This is a spontaneous report received from contactable reporter (Other HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Jan2021 as dose 2, single (Lot number: FJ9262) at the age of 52 years intramuscular, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EJ1686, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 30Dec2020, when the patient was 52-year-old, for COVID-19 immunization. The following information was reported: THROMBOSIS (medically significant) with onset 14Jul2021, outcome "recovering", described as "Developed blood clots in left calf". The event "developed blood clots in left calf" required physician office visit. Therapeutic measures were taken as a result of thrombosis. Clinical course: There were no other vaccine in four weeks and no other medications in two weeks. The event (AE) resulted in: Doctor or other healthcare professional office/clinic visit. AE treatment included ultrasound, baby aspirin. The patient had no COVID prior vaccination and not COVID tested post vaccination, The patient has no known allergy and no other medical history. The patient received dose number 3 of COVID 19 vaccine (Pfizer) on 19Jan2022 (Lot number: FJ6369), Intramuscular on left arm.; Sender's Comments: Based on the available information and the known product safety profile, a causal relationship between the reported event thrombosis and BNT162B2 is considered possible. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, Interchange of vaccine products
Clinical narrative: COVID 19 Treatment; COVID 19 Treatment; Dose 1 and 2= Moderna /Dose 3= Pfizer; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 65-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Jun2023 at 08:00 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 64 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 11Oct2021 at 09:00 as dose 1, single (Batch/Lot number: unknown), in left arm and on 09Nov2022 at 09:00 as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Benign prostatic hyperplasia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 21Jun2023 at 08:00, outcome "unknown", described as "Dose 1 and 2= Moderna /Dose 3= Pfizer"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information and the known product safety profile, a causal relationship between the reported events interchange of vaccine products, drug effective, COVID-19 and BNT162b2, BNT162b2 omi ba.4-5 is considered possible.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Dizziness, Dyspnoea, Hypersensitivity, Palpitations
Clinical narrative: pass out; felt she had breathing problems; her heart was racing; clamminess; dizziness; allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (pass out), DYSPNOEA (felt she had breathing problems), PALPITATIONS (her heart was racing), COLD SWEAT (clamminess) and DIZZINESS (dizziness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Drug use for unknown indication: Benadryl and Visine (she had complete redness around her eyelids and big red patches on her cheeks). Past adverse reactions to the above products included No adverse event with Benadryl; and Redness with Visine.    In February 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced HYPERSENSITIVITY (allergic reaction). On an unknown date, the patient experienced PRESYNCOPE (pass out), DYSPNOEA (felt she had breathing problems), PALPITATIONS (her heart was racing), COLD SWEAT (clamminess) and DIZZINESS (dizziness). At the time of the report, PRESYNCOPE (pass out), DYSPNOEA (felt she had breathing problems), PALPITATIONS (her heart was racing), COLD SWEAT (clamminess), DIZZINESS (dizziness) and HYPERSENSITIVITY (allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was unknown that patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. It was reported that patient has had similar reactions since after using Visine and Benadryl.  It was reported that patient believes her symptoms may be an allergic reaction to PEG or propylene glycol included in these medications. Treatment medications included PEG or propylene glycol.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Presyncope
Clinical narrative: pass out; felt she had breathing problems; her heart was racing; clamminess; dizziness; allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (pass out), DYSPNOEA (felt she had breathing problems), PALPITATIONS (her heart was racing), COLD SWEAT (clamminess) and DIZZINESS (dizziness) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for Drug use for unknown indication: Benadryl and Visine (she had complete redness around her eyelids and big red patches on her cheeks). Past adverse reactions to the above products included No adverse event with Benadryl; and Redness with Visine.    In February 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced HYPERSENSITIVITY (allergic reaction). On an unknown date, the patient experienced PRESYNCOPE (pass out), DYSPNOEA (felt she had breathing problems), PALPITATIONS (her heart was racing), COLD SWEAT (clamminess) and DIZZINESS (dizziness). At the time of the report, PRESYNCOPE (pass out), DYSPNOEA (felt she had breathing problems), PALPITATIONS (her heart was racing), COLD SWEAT (clamminess), DIZZINESS (dizziness) and HYPERSENSITIVITY (allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was unknown that patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant medication details not reported by the reporter. It was reported that patient has had similar reactions since after using Visine and Benadryl.  It was reported that patient believes her symptoms may be an allergic reaction to PEG or propylene glycol included in these medications. Treatment medications included PEG or propylene glycol.
Sex: F
Vaccine: FLUX
Symptoms: Vaccination site pain
Clinical narrative: Will it hurt like when she gets the senior flu shot; Initial information received on 16-Aug-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves elderly female patient who reported that it hurt when she gets the senior flu shot  influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect influenza vaccine produced by unknown manufacturer (formulation; strength; expiry date; lot number not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation).  On an unknown date the patient was hurt like when she got the senior influenza vaccine shot  (vaccination site pain) (unknown latency).  It was reported, "Product safety warm transferred caller who was ordered DUPIXENT for Chronic Obstructive Pulmonary Disease and will take her loading dose today or tomorrow. She wants to know how long she needs to wait between the first and second injection of the loading dose? Consumer had questions about how to perform the injection and has watched the video. Wants to know if she can attempt it herself or should she go to the doctor's office? Will it hurt like when she gets the senior flu shot but doesn't know a name of the flu shot? Agency reviewed injection technique and informed her everyone is different about whether the injection hurts and she should contact her provider if she wants to go to the office for her first injection."   Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Chills, Dizziness, Feeling abnormal, Flushing
Clinical narrative: This was my second shingrix vaccine. For both, I experienced chills, headache, fever, severe body aches, flushing of the face, dizziness, stomach upset. I am not a hypochondriac, but I can easily say this is the worst I have felt in a very long time.  I almost didn?t get the second vaccine because it was so bad the first time, but I figured I would just muscle through.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Pain, Pyrexia, Vaccine positive rechallenge
Clinical narrative: This was my second shingrix vaccine. For both, I experienced chills, headache, fever, severe body aches, flushing of the face, dizziness, stomach upset. I am not a hypochondriac, but I can easily say this is the worst I have felt in a very long time.  I almost didn?t get the second vaccine because it was so bad the first time, but I figured I would just muscle through.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Confusional state, General physical health deterioration, Hypophagia, SARS-CoV-2 test positive
Clinical narrative: Presented w/ worsening confusion, poor oral intake, steady deterioration in health. Covid +, tx w/ dexamethasone
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Deep vein thrombosis, Haemorrhage intracranial, Hypoxia
Clinical narrative: Presented via EMS w/ n/v, weakness, syncopal episode at home. PCR Covid +, pneumonia. Tx / Remdesivir, solumedrol, O2. Next day dx of LLE DVT, refractory hypoxemia, bilat pulm. Embolism. Thrombolytics initiated resulting in intracranial hemorrhage.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pneumonia, Pulmonary embolism, SARS-CoV-2 test positive, Syncope
Clinical narrative: Presented via EMS w/ n/v, weakness, syncopal episode at home. PCR Covid +, pneumonia. Tx / Remdesivir, solumedrol, O2. Next day dx of LLE DVT, refractory hypoxemia, bilat pulm. Embolism. Thrombolytics initiated resulting in intracranial hemorrhage.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombolysis, Vomiting
Clinical narrative: Presented via EMS w/ n/v, weakness, syncopal episode at home. PCR Covid +, pneumonia. Tx / Remdesivir, solumedrol, O2. Next day dx of LLE DVT, refractory hypoxemia, bilat pulm. Embolism. Thrombolytics initiated resulting in intracranial hemorrhage.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Lethargy, SARS-CoV-2 test
Clinical narrative: Presented w/ weakness and diarrhea, lethargy. Tested Codvid
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Hypoxia, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Presented via EMS w/ AMS, weakness. Recently tested + for covid, tested + again on arrival. Hypoxic on O2, treated w/ Remdesivir, steroids, abx
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, Dehydration, Fatigue, Gait disturbance
Clinical narrative: Presented from SNF w/ hypotension,weakness, fatigue, difficulty ambulating, n/v X 1. Covid +, Tx for dehydration
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented from SNF w/ hypotension,weakness, fatigue, difficulty ambulating, n/v X 1. Covid +, Tx for dehydration
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, Hypoxia, Pyrexia
Clinical narrative: Presented via EMS w/ cough, SOB X 24 hrs, low grade fever, hypoxia. Covid +/pneumonia. Treated w/ O2, Decadron, zinc, vit C
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Presented via EMS w/ cough, SOB X 24 hrs, low grade fever, hypoxia. Covid +/pneumonia. Treated w/ O2, Decadron, zinc, vit C
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cough, Diarrhoea, Dyspnoea, Hypoxia
Clinical narrative: Presented via EMS w/ dyspnea, hypoxia, cough, diarrhea, fever. Covid +/pneumonia, tx w/ dexamethasone,
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Presented via EMS w/ dyspnea, hypoxia, cough, diarrhea, fever. Covid +/pneumonia, tx w/ dexamethasone,
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Symptom recurrence
Clinical narrative: ANGIOEDEMA, INIT 2/2/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive, Syncope
Clinical narrative: Presented after syncopal episode, prior to event had weakness. Covid + tx w/ Dexamethasone, Vit D/C and zinc
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Dyspnoea exertional, Fatigue, SARS-CoV-2 test positive
Clinical narrative: Presented w/ SOB, DOE, fatigue, tremor. Covid +
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Presented w/ SOB, DOE, fatigue, tremor. Covid +
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Presented via EMS w/ SOB, cough X2days, hypoxia on O2. Covid +, tx w/ O2, Decadron, Remdesivir
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, Oropharyngeal pain, Pneumonia
Clinical narrative: Presented w/ sepsis/pneumonia, SOB, sore throat, cough, chest congestion, wheezing. Covid + pneumonia. Tx w/ Remdesivir, Dexamethasone
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Sepsis, Wheezing
Clinical narrative: Presented w/ sepsis/pneumonia, SOB, sore throat, cough, chest congestion, wheezing. Covid + pneumonia. Tx w/ Remdesivir, Dexamethasone
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Dyspnoea, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Presented via EMS w/ SOB, hypoxia and recent Covid + test. Tx for covid pneumonia (steroids, Remdesivir, O2)
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cardiac arrest, Death
Clinical narrative: Presented w/ SOB, nausea, decreased appetite, has been on supplemental O2 at home for several years. Covid +. Expired after cardiac arrest secondary to acute chronic hypoxic/hypercarbic respiratory failure d/t to Covid 19 pneumonia
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea, Nausea, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Presented w/ SOB, nausea, decreased appetite, has been on supplemental O2 at home for several years. Covid +. Expired after cardiac arrest secondary to acute chronic hypoxic/hypercarbic respiratory failure d/t to Covid 19 pneumonia
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Chills, Cough, Dyspnoea
Clinical narrative: Presented w/ HA, fever, chills, chest discomfort, cough, SOB, leg pain and increased urination. Covid +, tx w/ O2, Remdesivir, Decadron
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pollakiuria, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Presented w/ HA, fever, chills, chest discomfort, cough, SOB, leg pain and increased urination. Covid +, tx w/ O2, Remdesivir, Decadron
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Fatigue, Hypoxia
Clinical narrative: Presented w/ n/v , fatigue, SOB, cough, hypoxia X  8-9 days, recently tested COVID+, tx w/ O2, Decadron, Remdesivir
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Presented w/ n/v , fatigue, SOB, cough, hypoxia X  8-9 days, recently tested COVID+, tx w/ O2, Decadron, Remdesivir
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Death, Hyporesponsive to stimuli, Hypotension
Clinical narrative: Presented after being found at home poorly responsive in bed after vomiting and w/ lethargy. In ED hypoxic and hypotensive. Found to have septic shock. Tested Covid +. Cause of death was progressive hypoxemic respiratory failure secondary to aspiration pneumonia and COVID19 pneumonia.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Lethargy, Pneumonia aspiration, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: Presented after being found at home poorly responsive in bed after vomiting and w/ lethargy. In ED hypoxic and hypotensive. Found to have septic shock. Tested Covid +. Cause of death was progressive hypoxemic respiratory failure secondary to aspiration pneumonia and COVID19 pneumonia.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Septic shock, Vomiting
Clinical narrative: Presented after being found at home poorly responsive in bed after vomiting and w/ lethargy. In ED hypoxic and hypotensive. Found to have septic shock. Tested Covid +. Cause of death was progressive hypoxemic respiratory failure secondary to aspiration pneumonia and COVID19 pneumonia.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, COVID-19 pneumonia, SARS-CoV-2 test positive
Clinical narrative: Presented w/ weakness. Covid + pneumonia tx w/ Decadron, zinc, Vit C
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cough, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Presented w/ SOB, cough, tested covid+ pneumonia. Tx w/ Decadron, O2, zinc,
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cognitive disorder, Confusional state, Fatigue, Hallucination
Clinical narrative: Presented w/ AMS, hypoxia, fatigue, cognitive decline over last 6 mths resulting in sundowning and hallucinations. Tested Covid+.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Mental status changes, SARS-CoV-2 test positive
Clinical narrative: Presented w/ AMS, hypoxia, fatigue, cognitive decline over last 6 mths resulting in sundowning and hallucinations. Tested Covid+.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Symptom recurrence
Clinical narrative: ALLERGIC REACTION, INIT 7/8/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 12.0
Sex: F
Vaccine: UNK, UNK, UNK
Symptoms: Wrong product administered
Clinical narrative: Patient was due for meningococcal vaccine and was administered Men B by mistake.
Age: 4.0
Sex: F
Vaccine: IPV, MMR, TDAP, VARCEL
Symptoms: Wrong product administered
Clinical narrative: Dtap (dose number 5 in series) was ordered. Nurse administered Tdap instead. Provider made aware and mother made aware. No harm to child.
Age: 4.0
Sex: M
Vaccine: MMRV
Symptoms: Flushing, Nausea, Pruritus, Rash
Clinical narrative: Patient returned to the office about an hour after injection with full body rash, itching, nausea, and flushing.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Obstructive sleep apnoea syndrome, Respiratory failure
Clinical narrative: OBSTRUCTIVE SLEEP APNEA ACUTE RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE HYPOXIA
Age: 63.0
Sex: F
Vaccine: HEPAB
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: soreness, redness, heat at injection site. Started approximately 24 hours after injection
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC15, RV5, DTPPVHBHPB, PNC15, RV5
Symptoms: Autoimmune haemolytic anaemia, Dehydration, Full blood count abnormal, Gene mutation identification test negative, Haemoglobin decreased
Clinical narrative: Patient started to look jaundice on the night of May 29th. Brought him to PCP on the 30th where he vomited, PCP stated his red blood cells were breaking down and to bring to ER. At this time patient was asleep and basically had no movement, extremely dehydrated. Once we got to the ER, doctors/nurses tried to get blood and confirmed his HGB was at a 3. He was given a blood transfusion, his HGB went up to a 5 so he was given another blood transfusion and his HGB went up to a 7.9. Over the next several days he was being monitored and was given a high dose of methylprednisolone. On June 1st his HGB went down to a 6.3 so he was given another blood transfusion with his blood type A+, his HGB went up to a 11.4. tested once per day. We were discharged on June 7th. He has been on prednisolone twice daily starting at 2.3ml and currently now taking 1.1ml twice daily. His steroids have been weaning weekly up until Aug 15th. He received his 6 month vaccines on Aug 8th and since then his HGB has dropped to a 10.8 on Aug 16th and is a 10.8 as of Aug 22. Diagnosis is Autoimmune Hemolytic Anemia
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC15, RV5, DTPPVHBHPB, PNC15, RV5
Symptoms: Jaundice, Mobility decreased, Red blood cell abnormality, Transfusion, Vomiting
Clinical narrative: Patient started to look jaundice on the night of May 29th. Brought him to PCP on the 30th where he vomited, PCP stated his red blood cells were breaking down and to bring to ER. At this time patient was asleep and basically had no movement, extremely dehydrated. Once we got to the ER, doctors/nurses tried to get blood and confirmed his HGB was at a 3. He was given a blood transfusion, his HGB went up to a 5 so he was given another blood transfusion and his HGB went up to a 7.9. Over the next several days he was being monitored and was given a high dose of methylprednisolone. On June 1st his HGB went down to a 6.3 so he was given another blood transfusion with his blood type A+, his HGB went up to a 11.4. tested once per day. We were discharged on June 7th. He has been on prednisolone twice daily starting at 2.3ml and currently now taking 1.1ml twice daily. His steroids have been weaning weekly up until Aug 15th. He received his 6 month vaccines on Aug 8th and since then his HGB has dropped to a 10.8 on Aug 16th and is a 10.8 as of Aug 22. Diagnosis is Autoimmune Hemolytic Anemia
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC15, RV5, DTPPVHBHPB, PNC15, RV5
Symptoms: Autoimmune haemolytic anaemia, Blood test abnormal, Cytogenetic analysis normal, Dehydration, Full blood count abnormal
Clinical narrative: Patient started to look jaundice on the night of May 29th. Brought him to PCP on the 30th where he vomited, PCP stated his red blood cells were breaking down and to bring to ER. At this time patient was asleep and basically had no movement, extremely dehydrated. Once we got to the ER, doctors/nurses tried to get blood and confirmed his HGB was at a 3. He was given a blood transfusion, his HGB went up to a 5 so he was given another blood transfusion and his HGB went up to a 7.9. Over the next several days he was being monitored and was given a high dose of methylprednisolone. On June 1st his HGB went down to a 6.3 so he was given another blood transfusion with his blood type A+, his HGB went up to a 11.4. tested once per day. We were discharged on June 7th. He has been on prednisolone twice daily starting at 2.3ml and currently now taking 1.1ml twice daily. His steroids have been weaning weekly up until Aug 15th. He received his 6 month vaccines on Aug 8th and since then his HGB has dropped to a 10.8 on Aug 16th and is a 10.8 as of Aug 22. Diagnosis is Autoimmune Hemolytic Anemia
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC15, RV5, DTPPVHBHPB, PNC15, RV5
Symptoms: Gene mutation identification test negative, Haemoglobin decreased, Jaundice, Mobility decreased, Red blood cell abnormality
Clinical narrative: Patient started to look jaundice on the night of May 29th. Brought him to PCP on the 30th where he vomited, PCP stated his red blood cells were breaking down and to bring to ER. At this time patient was asleep and basically had no movement, extremely dehydrated. Once we got to the ER, doctors/nurses tried to get blood and confirmed his HGB was at a 3. He was given a blood transfusion, his HGB went up to a 5 so he was given another blood transfusion and his HGB went up to a 7.9. Over the next several days he was being monitored and was given a high dose of methylprednisolone. On June 1st his HGB went down to a 6.3 so he was given another blood transfusion with his blood type A+, his HGB went up to a 11.4. tested once per day. We were discharged on June 7th. He has been on prednisolone twice daily starting at 2.3ml and currently now taking 1.1ml twice daily. His steroids have been weaning weekly up until Aug 15th. He received his 6 month vaccines on Aug 8th and since then his HGB has dropped to a 10.8 on Aug 16th and is a 10.8 as of Aug 22. Diagnosis is Autoimmune Hemolytic Anemia
Age: 0.33
Sex: M
Vaccine: DTPPVHBHPB, PNC15, RV5, DTPPVHBHPB, PNC15, RV5
Symptoms: Transfusion, Vomiting
Clinical narrative: Patient started to look jaundice on the night of May 29th. Brought him to PCP on the 30th where he vomited, PCP stated his red blood cells were breaking down and to bring to ER. At this time patient was asleep and basically had no movement, extremely dehydrated. Once we got to the ER, doctors/nurses tried to get blood and confirmed his HGB was at a 3. He was given a blood transfusion, his HGB went up to a 5 so he was given another blood transfusion and his HGB went up to a 7.9. Over the next several days he was being monitored and was given a high dose of methylprednisolone. On June 1st his HGB went down to a 6.3 so he was given another blood transfusion with his blood type A+, his HGB went up to a 11.4. tested once per day. We were discharged on June 7th. He has been on prednisolone twice daily starting at 2.3ml and currently now taking 1.1ml twice daily. His steroids have been weaning weekly up until Aug 15th. He received his 6 month vaccines on Aug 8th and since then his HGB has dropped to a 10.8 on Aug 16th and is a 10.8 as of Aug 22. Diagnosis is Autoimmune Hemolytic Anemia
Age: 16.0
Sex: M
Vaccine: MMR
Symptoms: No adverse event, Wrong product administered
Clinical narrative: I (the provider) went to put in Meningococcal order into the computer and clicked off MMR.  Patient received a dose of MMR  instead of meningococcal due to incorrect computer order.
Age: 7.0
Sex: M
Vaccine: HEP, HEPA, IPV, MMRV, TDAP
Symptoms: Epistaxis, Nasal dryness, Pyrexia
Clinical narrative: Mother reports that child told her he ran a fever and had nosebleeds post vaccination. Mother is not able to tell this nurse other details as she states child is currently with other parent. Contacted father and he states that 1 week post vaccination (8/18) child ran a 99.2 fever, continued low grade fever until 8/21 and also had a couple of mild nosebleeds he attributed to child having a "dry nose". Reports no other symptoms that occurred thus far post vaccination.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: No adverse event, Wrong product administered
Clinical narrative: I mistakenly gave the client the diluent only for the 2 vial formulation of Menveo, not adding the powdered vaccine. It was dose 2 for the client. The client was called on 8/21/23 to report the mistake. A message was left with the client and he returned the call later that evening. The client had no adverse reaction. The outcome/treatment will be to repeat dose 2 of the Menveo series when he comes in to have dose 2 of Men B. The client will be home in November and the series will both be completed at that time
Age: 68.0
Sex: F
Vaccine: UNK
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Local reaction
Clinical narrative: localized reaction, Left upper arm redness, warmth, tenderness, swelling. Symptoms started on day of vaccination, 8/21/23, with progression
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Transient ischaemic attack
Clinical narrative: G45.9 TRANSIENT CEREBRAL ISCHEMIA 4/10/2023 ATRIAL FIBRILLATION, PAROXYSMAL
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Deep vein thrombosis, Hypoxia, Pneumonia, Pulmonary embolism
Clinical narrative: I26.99 ACUTE PULMONARY EMBOLISM 3/9/2023 BILAT PNEUMONIA I82.409 ACUTE DVT, UNSPECIFIED VEIN 3/21/2023 BILAT PNEUMONIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/4/2023 BILAT PNEUMONIA R09.02 HYPOXEMIA 4/7/2023 BILAT PNEUMONIA
Age: 13.0
Sex: F
Vaccine: HPV9
Symptoms: Extra dose administered
Clinical narrative: HPV#3 was given in error.  Pt has already completed two doses.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Hypersensitivity, Osteoarthritis
Clinical narrative: ALLERGIC REACTION, INIT 4/8/2023 CHEST PAIN ALLERGIC REACTION, INIT 4/8/2023 OSTEOARTHRITIS OF RIGHT HIP
Age: 10.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Inappropriate schedule of product administration
Clinical narrative: I gave the second dose of Hepatitis A too early. Patient received the first dose 5/1/2023 and wasn't due until 6 months later in November.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Diabetic nephropathy, Hypoxia, Magnetic resonance imaging abdominal abnormal, Type 2 diabetes mellitus, Urinary tract infection
Clinical narrative: HYPOXIA 4/4/2023 ABNL ABDOMINAL IMAGING HYPOXIA 4/4/2023 DM 2 W RENAL MANIFESTATION HYPOXIA 4/4/2023 UTI (URINARY TRACT INFECTION)
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Reversible ischaemic neurological deficit
Clinical narrative: I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/26/2023 ATRIAL FIBRILLATION, UNSPECIFIED I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/26/2023 ATRIAL FIBRILLATION, UNSPECIFIED
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthma, Hypoxia
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 ASTHMA, UNSPECIFIED R09.02 HYPOXIA 4/17/2023 ASTHMA, UNSPECIFIED
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Diverticular perforation, Diverticulitis, Hypoxia
Clinical narrative: HYPOXIA 3/21/2023 DIVERTICULITIS OF SIGMOID W PERFORATION
Age: 8.0
Sex: F
Vaccine: HEPA
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: No bad reactions.  The vaccine that the patient was supposed to receive was hepatitis B, NOT hepatitis A.  Therefore, the patient received an extra dose of hepatitis A
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The patient was administered an expired dose of COVID-19 vaccine after the unfrozen date.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic kidney disease, Metabolic encephalopathy, Nephrogenic anaemia, Reversible ischaemic neurological deficit
Clinical narrative: I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/22/2023 ANEMIA DUE TO CKD I63.9 REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME 4/22/2023 METABOLIC ENCEPHALOPATHY
Age: 14.0
Sex: F
Vaccine: HPV9, MMR, MNQ, TDAP, VARCEL
Symptoms: Hypotension, Syncope
Clinical narrative: At 10:13 am, patient experienced syncope and hypotension. No loss of consciousness. Patient laid down with feet elevated and blood pressure taken. Cool compress applied  to forehead. Offered juice. Monitored blood pressure which returned to normal range at 10:20 am.  Patient consumed 8 oz juice and reported she felt better. Symptoms improved and patient monitored for an additional 15 minutes. Advised to seek emergency care if symptoms return again. Patient left clinic at 10:40 am with adult guardian.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Diarrhoea, Immunisation reaction, Nausea, Skin warm, Vomiting
Clinical narrative: Adverse reaction to vaccine; Grandmother noticed Tuesday morning, worsened over the course of the day, was larger this morning, no other rashes noted, no difficulty breathing, acting normal otherwise, without fever/chills, N/V/D; not bothersome to patient but Grandmother notes its warm to touch and slightly larger in size.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 82.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Erythema
Clinical narrative: Local redness on LD, no pain
Age: 26.0
Sex: F
Vaccine: TYP
Symptoms: Incorrect route of product administration
Clinical narrative: On 15AUG2023, it was discovered that a Typhoid vaccine was administered via wrong route on 11AUG2023 as per clinic SOP.  Vaccine was given Subcutaneous on the Pt's left outer aspect arm vice IM per SOP.  As per manufacturer, the preferred route is IM; but SC is also allowed.    The chain of command was notified on the evening of 22AUG2023, and action was immediately taken on the morning of 23AUG2023.  Pt was contacted after a debrief with the Immunization Nurse.  Pt verified the location that the vaccine was given and denies any adverse reactions and has no concerns with the typhoid vaccine at this time.    Additional training has been assigned and further instruction and guidance has been provided.  In order to mitigate this current event and prevent any further issues, a more detailed training will be implemented, and a full review of all competencies will be conducted.  Safety stand-down will occur to discuss the 5 rights of Patient Care.
Age: 14.0
Sex: M
Vaccine: UNK
Symptoms: Wrong product administered
Clinical narrative: Men B was administered instead of Meningococcal vaccine
Age: 0.5
Sex: F
Vaccine: DTPPVHBHPB, PNC13, RV1, DTPPVHBHPB, PNC13, RV1
Symptoms: Pyrexia
Clinical narrative: developed fever higher than expected - 103.9 without other symptoms
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA
Age: 0.67
Sex: F
Vaccine: PNC20
Symptoms: Wrong product administered
Clinical narrative: See Item 9 for explanation
Age: 11.0
Sex: F
Vaccine: HEP, HEPA, HPV9, IPV, MMR, VARCEL
Symptoms: Breath holding, Fall, Headache, Loss of consciousness, Myalgia
Clinical narrative: After receiving the vaccines, the patient stood up and experienced some syncope, then passed out.  She was quickly woken up and was guided to a chair.  She was not injured from the fall and it was discovered that she had not had anything to eat or drink that day.  The step father went and grabbed some orange juice that seemed to help.   Another potential contributing factor may have been that she had been holding her breath.  I followed up with the family about an hour after.  Patient reported a very mild headache and mild sore neck muscles.  I again followed up with the parents the following day and she seemed to be doing well.
Age: 11.0
Sex: F
Vaccine: HEP, HEPA, HPV9, IPV, MMR, VARCEL
Symptoms: Syncope
Clinical narrative: After receiving the vaccines, the patient stood up and experienced some syncope, then passed out.  She was quickly woken up and was guided to a chair.  She was not injured from the fall and it was discovered that she had not had anything to eat or drink that day.  The step father went and grabbed some orange juice that seemed to help.   Another potential contributing factor may have been that she had been holding her breath.  I followed up with the family about an hour after.  Patient reported a very mild headache and mild sore neck muscles.  I again followed up with the parents the following day and she seemed to be doing well.